Navigation Links
Creatine Supplement May Help People With Muscular Dystrophies

in treating muscle disease.

The Cochrane researchers reviewed 12 studies that included 266 people with different types of muscular dystrophy. People in the studies who took creatine supplements used them for three weeks to six months.

In muscular dystrophies, the proteins that make up the muscles themselves are either missing or damaged. In a related group of disorders called metabolic myopathies, the chemicals that help muscles operate go awry.

Although creatine seemed to help many patients with muscular dystrophies, those with metabolic myopathies gained no more muscle strength or lean body mass than patients who did not use the supplement.

The reason for the contrasting results — creatine’s “fairly consistent” effects in muscular dystrophy and lack of effectiveness in metabolic diseases — is “not entirely clear,” Kley said, calling for more research on treatment for metabolic disorders.

The review was supported by the Neuromuscular Center Ruhrgebiet/Kliniken Bergmannsheil, at Ruhr-University Bochum and the Hamilton Health Sciences Corporation, in Canada. Kley and colleagues have each participated in trials of creatine treatment for muscle disorders, although none of the studies was sponsored by a maker of creatine.

Source-Newswie
SRM
'"/>




Page: 1 2

Related medicine news :

1. Creatine Helps Strengthen Older Men
2. NIH Announces Phase III Clinical Trial of Creatine for Parkinsons Disease
3. B Vitamin Supplementatoin Saves Money and Lives
4. Supplement helps cardiac surgery
5. Mislabeled Body-building Steroid Supplements
6. Garlic Supplements Impede HIV Therapy
7. Lactobacillus Supplements shorten the duration of diarrhoea
8. Supplements for Ear Infections
9. Babies Should Get Vitamin D Supplement
10. Benefits of Vitamin Supplements Unclear
11. Vitamin- B Supplements Beneficial in Depression Treatment
Post Your Comments:
Breaking Medicine Technology:Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Abbott Announces TCT 2009 Activities 57402 1Abbott Announces TCT 2009 Activities 57402 2Abbott Announces TCT 2009 Activities 57402 3Abbott Announces TCT 2009 Activities 57402 4Abbott Announces TCT 2009 Activities 57402 5PharmAbcine Closes USD 246 Million Series A Financing 14102 1PharmAbcine Closes USD 246 Million Series A Financing 14102 2PharmAbcine Closes USD 246 Million Series A Financing 14102 3PharmAbcine Closes USD 246 Million Series A Financing 14102 4The Simmons Firm to Host Midwest Asbestos Litigation Conference 57399 1The Simmons Firm to Host Midwest Asbestos Litigation Conference 57399 2